Minimal change nephrotic syndrome associated with non-hodgkin lymphoid disorders: A retrospective study of 18 cases

Medicine (United States)

Volumn 93, Issue 24, 2014, Pages 350-358

  Kofman, Tomek ^a,b   Zhang, Shao Yu ^b   Copie Bergman, Christiane ^a,b   Moktefi, Anissa ^a,b   Raimbourg, Quentin ^c   Francois, Hélène ^d   Karras, Alexandre ^c   Plaisier, Emmanuelle ^d   Painchart, Bernard ^e   Favre, Guillaume ^f   Bertrand, Dominique ^g   Gyan, Emmanuel ^h   Souid, Marc ⁱ   Roos Weil, Damien ^j   Desvaux, Dominique ^a,b   Grimbert, Philippe ^a,b   Haioun, Corinne ^a,b   Lang, Philippe ^a,b   Sahali, Djillali ^a,b   Audard, Vincent ^a,b  

^a HENRI MONDOR HOSPITAL   (France)

^b UNIVERSITÉ PARIS EST CRÉTEIL   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d INSERM   (France)

^e Centre Hospitalier de Cambrai   (France)

^f UNIVERSITÉ CÔTE D'AZUR   (France)

^g UNIVERSITÉ DE ROUEN   (France)

^h UNIVERSITY HOSPITAL OF TOURS   (France)

ⁱ CENTRE HOSPITALIER INTERCOMMUNAL   (France)

^j SORBONNE UNIVERSITÉ   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; CHLORAMBUCIL; CREATININE; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DOXORUBICIN; FLUDARABINE; PARAPROTEIN; PREDNISONE; RITUXIMAB; VINCRISTINE;

ACUTE KIDNEY FAILURE; ADULT; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CELL INFILTRATION; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; CLINICAL FEATURE; CREATININE BLOOD LEVEL; DISEASE ASSOCIATION; DRUG RESPONSE; FEMALE; HUMAN; HUMAN TISSUE; KIDNEY BIOPSY; KIDNEY INTERSTITIUM; KIDNEY ISCHEMIA; KIDNEY TUBULE DAMAGE; MALE; MANTLE CELL LYMPHOMA; MARGINAL ZONE LYMPHOMA; MIDDLE AGED; MINIMAL CHANGE NEPHROTIC SYNDROME; MULTIPLE MYELOMA; NEPHROTIC SYNDROME; NONHODGKIN LYMPHOMA; PERIPHERAL T CELL LYMPHOMA; PRIORITY JOURNAL; PROTEINURIA; RELAPSE; RETROSPECTIVE STUDY; STEROID THERAPY; VERY ELDERLY; WALDENSTROEM MACROGLOBULINEMIA; B CELL LYMPHOMA; COMPLICATION; NEPHROSIS, LIPOID; PATHOLOGY; TIME;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; LYMPHOMA, B-CELL; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; NEPHROSIS, LIPOID; RETROSPECTIVE STUDIES; TIME FACTORS; WALDENSTROM MACROGLOBULINEMIA;

EID: 84926065851     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0000000000000206     Document Type: Article

References (37)

1. Aggarwal N, Batwara R, McCarthy ET, et al. Serum permeability activity in steroid-resistant minimal change nephrotic syndrome is abolished by treatment of Hodgkin disease. Am J Kidney Dis. 2007;50:826-829.
2. Anonymous. Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group. Br J Haematol. 2003;121:749-757.
3. Audard V, Georges B, Vanhille P, et al. Renal lesions associated with IgM-secreting monoclonal proliferations: revisiting the disease spectrum. Clin. J Am Soc Nephrol. 2008;3:1339-1349.
4. Audard V, Larousserie F, Grimbert P, et al. Minimal change nephrotic syndrome and classical Hodgkin's lymphoma: report of 21 cases and review of the literature. Kidney Int. 2006;69:2251-2260.
5. Audard V, Zhang SY, Copie-Bergman C, et al. Occurrence of minimal change nephrotic syndrome in classical Hodgkin lymphoma is closely related to the induction of c-mip in Hodgkin-Reed Sternberg cells and podocytes. Blood. 2010;115:3756-3762.
6. Basnayake K, Stringer SJ, Hutchison CA, et al. The biology of immunoglobulin free light chains and kidney injury. Kidney Int. 2011;79:1289-1301.
7. Belghiti D, Vernant JP, Hirbec G, et al. Nephrotic syndrome associated with T-cell lymphoma. Cancer. 1981;47:1878-1882.
8. Cambier JF, Ronco Onco-nephrology: P. Glomerular diseases with cancer. Clin J Am Soc Nephrol. 2012;7:1701-1712.
9. Clement LC, Avila-Casado C, Mace C, et al. Podocyte-secreted angiopoietin-like-4 mediates proteinuria in glucocorticoid-sensitive nephrotic syndrome. Nat Med. 2011;17:117-122.
10. Cohen LJ, Rennke HG, Laubach JP, et al. The spectrum of kidney involvement in lymphoma: a case report and review of the literature. Am J Kidney Dis. 2010;56:1191-1196.
11. Da'as N, Polliack A, Cohen Y, et al. Kidney involvement and renal manifestations in non-Hodgkin's lymphoma and lymphocytic leukemia: a retrospective study in 700 patients. Eur J Haematol. 2001;67:158-164.
12. Farrell K, Jarrett RF. The molecular pathogenesis of Hodgkin lymphoma. Histopathology. 2011;58:15-25.
13. Ghiggeri GM, Bleid D, Garaventa A, et al. Recurrent lymphomatoid papulosis associated with nephrotic syndrome. An occurrence of uncertain origin. Pediatr Nephrol. 2009;24:189-192.
14. Ghobrial IM, Gertz MA, Fonseca R. Waldenstrom macroglobulinaemia. Lancet Oncol. 2003;4:679-685.
15. Hallek M, Cheson BD, Catovsky D, et al. Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines. Blood. 2008;111:5446-5456.
16. Harris NL, Jaffe ES, Diebold J, et al. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997. J Clin Oncol. 1999;17:3835-3849.
17. Hory B, Saunier F, Wolff R, et al. Waldenstrom macroglobulinemia and nephrotic syndrome with minimal change lesion. Nephron. 1987;45:68-70.
18. Ishimoto T, Shimada M, Araya CE, et al. Minimal change disease: a CD80 podocytopathy? Semin Nephrol. 2011;31:320-325.
19. Jhaveri KD, Shah HH, Calderon K, et al. Glomerular diseases seen with cancer and chemotherapy: a narrative review. Kidney Int. 2013;84:34-44.
20. Kasmani R, Marina VP, Abidi S, et al. Minimal change disease associated with MALT lymphoma. Int Urol Nephrol. 2012;44:1911-1913.
21. Kowalewska J, Nicosia RF, Smith KD, et al. Patterns of glomerular injury in kidneys infiltrated by lymphoplasmacytic neoplasms. Hum Pathol. 2011;42:896-903.
22. Lien YH, Lai Pathogenesis LW. Diagnosis and management of paraneoplastic glomerulonephritis. Nat Rev Nephrol. 2011;7:85-95.
23. Mallick NP, Dosa S, Acheson EJ, et al. Detection, significance and treatment of paraprotein in patients presenting with proteinuria without myeloma. Q J Med. 1978;47:145-175.
24. Mathieson PW. Minimal change nephropathy and focal segmental glomerulosclerosis. Semin Immunopathol. 2007;29:415-426.
25. Mehta R, Kellum J, Shah S, et al. The Acute Kidney Injury N. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Critical Care. 2007;11:R31.
26. Moulin B, Ronco PM, Mougenot B, et al. Glomerulonephritis in chronic lymphocytic leukemia and related B-cell lymphomas. Kidney Int. 1992;42:127-135.
27. Nakayama S, Yokote T, Kobayashi K, et al. Minimal-change nephrotic syndrome preceding Hodgkin lymphoma by 5 years with expression of tumor necrosis factor alpha in Hodgkin-Reed- Sternberg cells. Hum Pathol. 2010;41:1196-1199.
28. Ronco PM. Paraneoplastic glomerulopathies: new insights into an old entity. Kidney Int. 1999;56:355-377.
29. Swerdlow SHCE, Harris NL, Jaffe ES, et al. Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th ed. Lyon, France: IARC (International Agency for Research on Cancer) Press; 2008.
30. Tavares MB, Chagas de Almeida Mda C, Martins RT, et al. Acute tubular necrosis and renal failure in patients with glomerular disease. Ren Fail. 2012;34:1252-1257.
31. Terrier B, Buzyn A, Hummel A, et al. Serum monoclonal component and nephrotic syndrome-it is not always amyloidosis. Diagnosis: WM complicated by retroperitoneal and renal infiltration and associated with a minimal change disease. Nephrol Dial Transplant. 2006;21:3327-3329.
32. Tornroth T, Heiro M, Marcussen N, et al. Lymphomas diagnosed by percutaneous kidney biopsy. Am J Kidney Dis. 2003;42:960-971.
33. Van den Berg JW, JJ. Role of the immune system in the pathogenesis of idiopathic nephrotic syndrome. Clin Sci. 2004;107:125-136.
34. Waldman M, Crew RJ, Valeri A, et al. Adult minimal-change disease: clinical characteristics, treatment, and outcomes. Clin J Am Soc Nephrol. 2007;2:445-453.
35. Wei C, El Hindi S, Li J, et al. Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis. Nat Med. 2011;17: 952-960.
36. Zhang SY, Audard V, Fan Q, et al. Immunopathogenesis of idiopathic nephrotic syndrome. Contrib Nephrol. 2011;169:94-106.
37. Zhang SY, Kamal M, Dahan K, et al. C-mip impairs podocyte proximal signaling and induces heavy proteinuria. Sci Signal. 2010;3:ra39. |.